|
|
 |
|
Viewing report
|
|
|
|
Chinese and Taiwanese Markets for Spinal Implants, MIS and VCF 2011 (Executive Summary)
iData Research, Oct 2011
The combined Chinese and Taiwanese spinal implant market is expected to exceed $1 billion by 2017, driven by the rapid expansion of all markets in China.
The combined Chinese and Taiwanese spinal implant market comprises three main segments:
- spinal fusion implants,
- non-fusion implants and
- vertebral compression fracture (VCF) treatments.
Despite the geographical proximity of China and Taiwan, the spinal implant markets in these two countries differ substantially. The Taiwanese market is mature and stable. As a result, the majority of growth in the Taiwanese market is due to the proliferation of newer technologies, including artificial discs, percutaneous vertebral augmentation (PVA) and minimally invasive surgery (MIS) solutions. Conversely, in China, increasing access to healthcare in rural areas, growing healthcare investment and a rise in the number of trained orthopedic surgeons have led to rapid growth in nearly every spinal implant market segment.
Within the Chinese and Taiwanese market for spinal implants, companies such as Depuy, Medtronic, Stryker and Synthes lead the market, among many domestic companies, particularly in China. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
This is an executive summary only, the full-report is also available for purchase.
Also available
Chinese and Taiwanese Markets for Spinal Implants, MIS and VCF 2011
|
|
|
|
